Literature DB >> 8092598

Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction.

J F Tucker1, R A Collins, A J Anderson, M Hess, I M Farley, D A Hagemann, H J Harkins, D Zwicke.   

Abstract

STUDY
OBJECTIVE: The potential for missing the diagnosis of acute myocardial infarction (AMI) and the need for appropriate use of ICU beds make early and accurate diagnostic tests to assist in this diagnosis valuable. We studied the use of serial myoglobin determinations for patients evaluated in the emergency department and admitted for possible AMI.
DESIGN: Over a 3.5-month period, all patients presenting to the ED and admitted for suspected cardiac symptoms had serial cardiac enzymes obtained prospectively at admission and 2, 3, 4, and 6 hours after the onset of symptoms.
SETTING: Large urban community hospital. PARTICIPANTS: One hundred thirty-three consecutive patients admitted to treat or rule out AMI.
RESULTS: Twenty-one of 22 patients with an initially normal myoglobin that doubled within 1 to 2 hours after presentation were positive for AMI (specificity, 95%). Sensitivity of myoglobin at 2 hours after the onset of symptoms was 37% and rose to 86% at 6 hours, with 95% specificity. The negative predictive value if myoglobin was normal at 6 hours and had not doubled within 2 hours was 97% (positive predictive value, 88%).
CONCLUSION: A repeat myoglobin level that doubled within 1 to 2 hours after the initial value, even if still within the normal range, was highly specific for AMI. Serial myoglobin levels may be useful in earlier identification of AMI to help prevent inappropriate discharge from the ED and for appropriate placement in ICU beds.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092598     DOI: 10.1016/s0196-0644(94)70282-9

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  8 in total

Review 1.  Plasmonic technology: novel approach to ultrasensitive immunoassays.

Authors:  Joseph R Lakowicz; Joanna Malicka; Evgenia Matveeva; Ignacy Gryczynski; Zygmunt Gryczynski
Journal:  Clin Chem       Date:  2005-07-28       Impact factor: 8.327

2.  Microwave-accelerated metal-enhanced fluorescence (MAMEF): application to ultra fast and sensitive clinical assays.

Authors:  Kadir Aslan; Chris D Geddes
Journal:  J Fluoresc       Date:  2005-12-22       Impact factor: 2.217

3.  Biochemical markers in the management of suspected acute myocardial infarction in the emergency department.

Authors:  A M Huggon; J Chambers; N Nayeem; P Tutt; M Crook; S Swaminathan
Journal:  Emerg Med J       Date:  2001-01       Impact factor: 2.740

4.  Current Status of Novel Biomarkers for the Diagnosis of Acute Kidney Injury: A Historical Perspective.

Authors:  Benjamin R Griffin; Katja M Gist; Sarah Faubel
Journal:  J Intensive Care Med       Date:  2019-01-17       Impact factor: 3.510

5.  A prospective study of an algorithm using cardiac troponin I and myoglobin as adjuncts in the diagnosis of acute myocardial infarction and intermediate coronary syndromes in a veteran's hospital.

Authors:  A S Maisel; K Templin; M Love; P Clopton
Journal:  Clin Cardiol       Date:  2000-12       Impact factor: 2.882

6.  Myoglobin immunoassay utilizing directional surface plasmon-coupled emission.

Authors:  Evgenia Matveeva; Zygmunt Gryczynski; Ignacy Gryczynski; Joanna Malicka; Joseph R Lakowicz
Journal:  Anal Chem       Date:  2004-11-01       Impact factor: 6.986

7.  Isobaric tags for relative and absolute quantitation‑based proteomics reveals potential novel biomarkers for the early diagnosis of acute myocardial infarction within 3 h.

Authors:  Changqing Du; Yingzheng Weng; Jiangjie Lou; Guangzhong Zeng; Xiaowei Liu; Hongfeng Jin; Senna Lin; Lijiang Tang
Journal:  Int J Mol Med       Date:  2019-03-19       Impact factor: 4.101

8.  Microwave-Accelerated and Metal-Enhanced Fluorescence Myoglobin Detection on Silvered Surfaces: Potential Application to Myocardial Infarction Diagnosis.

Authors:  Kadir Aslan; Chris D Geddes
Journal:  Plasmonics       Date:  2006-03-01       Impact factor: 2.404

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.